FIELD: medicine.
SUBSTANCE: present invention refers to pharmaceutics and medicine and concerns applications of phenothiazine derivative to produce a medical product used to prevent and/or treat hearing loss.
EFFECT: means ensures high clinical effectiveness.
20 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPY OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY | 2005 |
|
RU2380094C2 |
| AGENT FOR SENSORINEURAL HEARING LOSS TREATMENT (VERSIONS) | 2015 |
|
RU2614487C1 |
| NEW COMPOUNDS USED AS POTASSIUM CHANNEL OPENERS | 2018 |
|
RU2779131C2 |
| NEW COMPOUNDS USED AS POTASSIUM CHANNEL OPENERS | 2018 |
|
RU2779111C2 |
| METHODS FOR THE TREATMENT OF COCHLEAR SYNAPTOPATHY | 2017 |
|
RU2757276C2 |
| FLUORINE-9-METHYL-β-CARBOLINES | 2014 |
|
RU2642785C2 |
| SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS FOR APPLICATION IN TREATMENT OF LESIONAL VESTIBULAR DISORDERS | 2010 |
|
RU2608458C2 |
| METHOD FOR THE TREATMENT OF ACUTE ACOUSTIC INJURY | 2022 |
|
RU2783255C1 |
| METHOD OF MODELING SENSONEURAL HEARING LOSS | 2016 |
|
RU2627155C1 |
| DIBENZO-AZEPINE COMPOUNDS AND USE THEREOF FOR TREATING EAR DISEASES AND DISORDERS | 2016 |
|
RU2707284C1 |
